首页> 外文期刊>Protein Expression and Purification >INVESTIGATION OF HUMAN CYCLOOXYGENASE-2 GLYCOSYLATION HETEROGENEITY AND PROTEIN EXPRESSION IN INSECT AND MAMMALIAN CELL EXPRESSION SYSTEMS
【24h】

INVESTIGATION OF HUMAN CYCLOOXYGENASE-2 GLYCOSYLATION HETEROGENEITY AND PROTEIN EXPRESSION IN INSECT AND MAMMALIAN CELL EXPRESSION SYSTEMS

机译:昆虫和哺乳动物细胞表达系统中人类环氧化酶-2糖基化异质性和蛋白质表达的研究

获取原文
获取原文并翻译 | 示例
       

摘要

Human cyclooxygenase-2 (hCox-2) is a key enzyme in the biosynthesis of prostaglandins and the target of nonsteroidal anti-inflammatory drugs. Recombinant hCox-2 overexpressed in a vaccinia virus (VV)-COS-7 system comprises two glycoforms. Removal of the N-glycosylation consensus sequence at Asn(580) (N580Q and S582A mutants) resulted in the expression of protein comprising a single glycoform, consistent with the partial N-glycosylation at this site in the wild-type (WT) enzyme. The specific cyclooxygenase activities of the purified WT and N580Q mutant were equivalent (40 +/- 3 mu mol O-2/min/mg) and titrations with diclofenac showed no difference in inhibitor sensitivities of WT and both mutants. Results of the expression of WT and N580Q hCox-2 in a Drosophila s2 cell system were also consistent with the N-glycosylation at this site, but low levels of activity were obtained. High levels of N-glycosylation heterogeneity are observed in hCox-2 expressed using recombinant baculovirus (BV) in Sf9 cells. Expression of a double N-glycosylation site mutant in Sf9 cells, N580Q/N592Q, resulted in a decrease in glycosylation but no clear decrease in heterogeneity, indicating that the high degree of N-glycosylation heterogeneity observed with the BV-Sf9 system is not due to partial glycosylation of both Asn(580) and Asn(592) N-linked oligosaccharide profiling of purified VV and BV WT and S582A mutant hCox-2 showed the presence of high mannose structures, (Man)(n)(GlcNAc)(2), n = 9, 8, 7, 6. The s582A mutant was the most homogeneous with (Man)(9)(GlcNAc)(2) comprising greater than 50% of oligosaccharides present. Analysis of purified VV WT and S582A mutant hCox-2 by liquid chromatography-electrospray ionization-mass spectrometry showed an envelope of peaks separated by approximately 160 Ha, corresponding to differences of a single monosaccharide. The difference between the highest mass peaks of the two envelopes, of approximately 1500 Da, is consistent with the wild-type enzyme containing an additional high mannose oligosaccharide. (C) 1997 Academic Press. [References: 33]
机译:人环氧合酶2(hCox-2)是前列腺素生物合成中的关键酶,也是非甾体类抗炎药的靶标。在牛痘病毒(VV)-COS-7系统中过表达的重组hCox-2包含两种糖型。去除Asn(580)上的N-糖基化共有序列(N580Q和S582A突变体)导致包含单一糖型的蛋白表达,与野生型(WT)酶在该位点的部分N-糖基化一致。纯化的WT和N580Q突变体的特异性环氧合酶活性是等效的(40 +/- 3μmol O-2 / min / mg),用双氯芬酸滴定显示WT和两个突变体的抑制剂敏感性没有差异。果蝇s2细胞系统中WT和N580Q hCox-2的表达结果也与该位点的N-糖基化一致,但活性较低。使用重组杆状病毒(BV)在Sf9细胞中表达的hCox-2中观察到高水平的N-糖基化异质性。 Sf9细胞N580Q / N592Q中双重N-糖基化位点突变体的表达导致糖基化程度降低,但异质性没有明显降低,这表明使用BV-Sf9系统观察到的N-糖基化异质性很高纯化的VV和BV的Asn(580)和Asn(592)N联寡糖的部分糖基化分析WT和S582A突变体hCox-2显示存在高甘露糖结构,(Man)(n)(GlcNAc)(2 ),n = 9、8、7、6。s582A突变体与(Man)(9)(GlcNAc)(2)所含寡糖含量超过50%的突变体最相似。通过液相色谱-电喷雾电离-质谱法分析纯化的VV WT和S582A突变体hCox-2的结果表明,峰的包络线分开了大约160 Ha,对应于单个单糖的差异。两个包膜的最高质量峰之间的差异约为1500 Da,这与含有额外的高甘露糖低聚糖的野生型酶一致。 (C)1997学术出版社。 [参考:33]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号